Lisinopril And Hydrochlorothiazide
Product Images NDC 54458-886

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 54458-886). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by International Labs, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lisinopril Chem Structure (Lisinopril And Hydrochlorothiazide 10mg12 5mg 1)

FDA Label Image

Hctz Chem Structure (Lisinopril And Hydrochlorothiazide 10mg12 5mg 2)

FDA Label Image

Lisinopril/hctz (Lisinopril And Hydrochlorothiazide 10mg12 5mg 3)

Lisinopril/hctz (Lisinopril And Hydrochlorothiazide 10mg12 5mg 3)
This is a medication containing Lisinopril/Hydrochlorothiazide in the form of tablets. Each tablet contains 10 mg of Lisinopril and 12.5 mg of Hydrochlorothiazide. The tablets are child-resistant and should be stored between 20°C and 25°C in a controlled room temperature, protected from light and humidity. The package comes with a medication card containing 30 tablets, and an accompanying drug information sheet. It is manufactured by Lupin Limited in India and packaged by International Laboratories in St. Petersburg, Florida.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.